Clinical Trials Logo

Uterine Hemorrhage clinical trials

View clinical trials related to Uterine Hemorrhage.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 2

NCT ID: NCT04290013 Not yet recruiting - Clinical trials for Dysfunctional Uterine Bleeding

Effects of Tranexemic Acid Versus Norethisterone Acetate on Endometrial Vasculature .

Start date: April 22, 2020
Phase: Phase 3
Study type: Interventional

Heavy periods is a significant problem in reproductive age .It affects about a third of women in the childbearing period Any of the following is considered to be heavy menstrual bleeding (Bleeding that lasts more than 7 days,Bleeding that soaks through one or more tampons or pads every hour for several hours in a row.Needing to wear more than one pad at a time to control menstrual flow.,Needing to change pads or tampons during the night or Menstrual flow with blood clots that are as big as a quarter or larger) . Heavy periods can be caused by organic cause as fibroids, adenomyosis, polyps or they can be dysfunctional.Dysfunctional uterine bleeding is irregular uterine bleeding that occurs in the absence of recognisable pelvic pathology, general medical disease, or pregnancy. It reflects a disruption in the normal cyclic pattern of ovulatory hormonal stimulation to the endometrial lining. Several treatment options include: hormonal treatment as norethisterone acetate,oral contraceptive pills, gonadotrophin releasing hormone analogue. ,tranexamic acid or non steroidal anti-inflammatory drugs. The investigators plan to do a comparative study between norethisterone acetate and tranexamic acid regarding their control of the heavy periods as well as their effect on the uterine and endometrial vasculature.

NCT ID: NCT03847415 Not yet recruiting - Clinical trials for Postmenopausal Bleeding

Endometrial Evaluation in Cases of Postmenopausal Bleeding

Start date: February 2019
Phase:
Study type: Observational

The aim of this prospective observational study is to evaluate abnormal uterine bleeding in postmenopausal women using 3D(dimensional) ultrasound assessment of endometrial volume .Doppler assessment of endometrium and hysteroscopy and to correlate this finding with pathological finding of endometrial biopsy

NCT ID: NCT03709849 Not yet recruiting - Clinical trials for Polycystic Ovarian Syndrome

Effectiveness and Safety of Bushen Culuan Decoction for Anovulatory Infertility

Start date: February 1, 2019
Phase: Phase 2
Study type: Interventional

This study is to evaluate the effectiveness and safety of Bushen Culuan Decoction in the treatment of anovulatory infertility, including anovulatory abnormal uterine bleeding, polycystic ovarian syndrome, hyperprolactinemia, luteinized unruptured follicle syndrome, corpus luteum insufficiency and ovarian insufficiency, through a randomised, double-blinded, double-dummy, parallel positive controlled, adaptive multicenter clinical trial.

NCT ID: NCT03205111 Not yet recruiting - Uterine Bleeding Clinical Trials

Role of Office Hysteroscope in Premenopausal Uterine Bleeding

Start date: July 2017
Phase: N/A
Study type: Observational

The aim of this study is to photographically characterize the endometrium in patients presenting with abnormal uterine bleeding at age group from 20 to 45 years old. and compare dilatation and curettage with hysteroscopy in obtaining an accurate diagnosis of the etiology of abnormal uterine bleeding.

NCT ID: NCT02453568 Not yet recruiting - Uterine Hemorrhage Clinical Trials

Use of Tranexamic Acid for Prevention of Postpartum Hemorrhage and Routine Blood Loss in Obstetrics

Start date: n/a
Phase: Phase 3
Study type: Interventional

The purpose of this study is to establish that routine administration of tranexamic acid during the third stage of labor effectively reduces blood loss in vaginal deliveries.

NCT ID: NCT01365676 Not yet recruiting - Clinical trials for Premenstrual Syndrome

GAMALINE®+HIPERICIN® for PMS Treatment and Vasomotor Symptoms

657/10UFCSPA
Start date: March 2012
Phase: Phase 3
Study type: Interventional

2 phytomedicines already in the market: GAMALINE® for premenstrual syndrome and HIPERICIN® as antidepressant will be prescribed together for treating women with Premenstrual Syndrome (PMS) symptoms and vasomotor problems for checking the advantage compared to the GAMALINE® prescription alone.